Related Experiment Videos

Overlapping connective tissue diseases in children

Clinical Rheumatology
|December 1, 1983
PubMed

Insights

Pediatric connective tissue disease (CTD) overlap syndromes are observed, but anti-ribonucleoprotein (anti-RNP) antibodies are not a reliable diagnostic marker in children with CTDs. Further research is needed to understand these complex conditions.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Connective Tissue Diseases

Background:

  • Connective tissue diseases (CTDs) can manifest with overlapping features in children.
  • Understanding these overlaps is crucial for accurate diagnosis and management.
  • The role of specific autoantibodies, like anti-ribonucleoprotein (anti-RNP), in pediatric CTDs requires clarification.

Purpose of the Study:

  • To investigate the occurrence and characteristics of overlapping connective tissue diseases in a pediatric cohort.
  • To evaluate the diagnostic utility of anti-ribonucleoprotein (anti-RNP) antibodies in children with CTDs.

Main Methods:

  • Retrospective analysis of 18 children diagnosed with various connective tissue diseases.
  • Clinical assessment for overlapping features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), polymyositis (PM), and juvenile rheumatoid arthritis (JRA).
  • Detection of anti-ribonucleoprotein (anti-RNP) antibodies using radial immunodiffusion.

Main Results:

  • Four out of 18 children exhibited overlapping CTD features, including combinations like SLE with PSS or PM, and SLE with PSS and JRA.
  • Anti-ribonucleoprotein (anti-RNP) antibodies were detected in two children with overlapping CTDs and in a few with single CTDs.
  • Children with anti-RNP antibodies did not show distinct clinical patterns or improved prognoses compared to those without, with fewer exhibiting Raynaud phenomenon, sausage fingers, or myositis than adults.

Conclusions:

  • Combinations of connective tissue diseases can occur in children.
  • Anti-ribonucleoprotein (anti-RNP) antibodies are not a specific or reliable biomarker for diagnosing CTD overlaps in the pediatric population.
  • Clinical presentation and prognosis in pediatric CTD overlaps show some differences from adult presentations.

Related Concept Videos